SCHEMBL5963219

SCHEMBL5963219

CC(C)(NC(=O)[C@@H](S)C1CCOCC1)C(=O)N[C@@H](CCc1ccccc1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACE P12821 10/20 0.42
MME P08473 5/20 0.42
ACE2 Q9BYF1 5/20 0.42
CPA1 P15085 4/20 0.42
CTSS P25774 4/20 0.39
CTSL P07711 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
CTSK P43235 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5963440 1.00 ACE (0.42) ACEMMEACE2CPA1CTSS
SCHEMBL5963614 0.91 ACE (0.42) ACECTSL
SCHEMBL3362555 0.86 PPARA (0.46) ACEMMEACE2CPA1CTSS
SCHEMBL3363745 0.81 CTSS (0.43) MMECTSSCTSLCTSK
SCHEMBL5963699 0.80 ACE (0.47) ACEMMEACE2CPA1MMP1
SCHEMBL5963752 0.78 ACE (0.60) ACE
SCHEMBL5963738 0.78 ACE (0.40) ACECTSL
SCHEMBL5963231 0.77 MME (0.45) ACEMMEACE2CPA1
SCHEMBL5963237 0.77 MME (0.45) ACEMMEACE2CPA1
SCHEMBL5964064 0.75 MME (0.43) ACEMMEACE2CPA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6995265-B2 Synthesis of nicotine derivatives from nicotine NORTH CAROLINA STATE UNIVERSITY (US) 2006-02-07 US disclosed
EP-1430045-A1 PYRANE DERIVATIVES AS BOTH ACE- AND NEP-INHIBITORS Novartis AG (CH) 2004-06-23 EP disclosed
WO-2003027091-A1 PYRANE DERIVATIVES AS BOTH ACE- AND NEP- INHIBITORS NOVARTIS AG (CH) 2003-04-03 WO disclosed